Emergex
  • About Us
      • Team
      • Board of Directors
      • Special Advisors
  • Technology
      • Advantages of Emergex’s Vaccines
      • Set-point Vaccines
  • Pipeline
  • Media Centre
      • Press Releases
      • In the News
      • White Papers
  • Contact Us
  • Menu Menu
You are here: Home1 / Media Centre2 / Press Releases3 / In the News

In the News

Nanotechnology World: Synthetic Vaccines – Addressing the “One Bug One Drug” Phenomenon

21 June 2018

View article

CNBC news interview with Emergex Vaccines CEO, Professor Thomas Rademacher

14 May 2018

BioWorld: Thinking on a global scale, Emergex Vaccines using lessons from Ebola outbreak

3 May 2018

LONDON – The lessons of the Ebola epidemic have come together with a series of scientific advances, and expertise acquired over a lifetime in biotech, to inspire a novel vaccine technology that is designed to provide genus-wide protection against viral infections.

View PDF

© EMERGEX VACCINES

Website maintained by Digital Trading

  • Contact Us
LinkedIn
Scroll to top